Skip to content

Evaluation of the efficacy of sphenopalatine block in headache in patients with non-traumatic subarachnoid hemorrhage (SAH) after training of neurosurgical intensive care nurses.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514282-19-00
Acronym
38RC23.0226 SATURN
Enrollment
70
Registered
2024-11-26
Start date
2025-05-30
Completion date
Unknown
Last updated
2024-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subarachnoid hemorrhage

Brief summary

Total morphine consumption in mg for the first 72 hours after cerebral arteriography in the ICU.

Detailed description

1. EN: (Simple Numerical Scale) 7-day average, 2. Morphine consumption in mg per day during hospitalization., 3. Complications of the sphenopalatine block technique: incidence of soft palate anesthesia (false routes to liquids at H+2), epistaxis, vasovagal reactions, transient hearing loss., 4. Number of BGSP failures, 5. EN at D28, consumption of stage 3 analgesics or neuropathic painkillers., 6. Overall pain management satisfaction questionnaire, 7. Satisfaction questionnaire for nurses

Interventions

DRUGsolution injectable
DRUGXYLOCAINE VISQUEUSE 2 %
DRUGgel oral
DRUGLIDOCAINE AGUETTANT 20 mg/mL SANS CONSERVATEUR

Sponsors

Centre Hospitalier Universitaire Grenoble Alpes
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Total morphine consumption in mg for the first 72 hours after cerebral arteriography in the ICU.

Secondary

MeasureTime frame
1. EN: (Simple Numerical Scale) 7-day average, 2. Morphine consumption in mg per day during hospitalization., 3. Complications of the sphenopalatine block technique: incidence of soft palate anesthesia (false routes to liquids at H+2), epistaxis, vasovagal reactions, transient hearing loss., 4. Number of BGSP failures, 5. EN at D28, consumption of stage 3 analgesics or neuropathic painkillers., 6. Overall pain management satisfaction questionnaire, 7. Satisfaction questionnaire for nurses

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026